The Brussels-based European Alliance for Personalised Medicine (EAPM) is today (5 March) playing a key role in the 3rd International Forum on Personalised Medicine in Warsaw,...
Much has been said about potential over-diagnosis and over-treatment as a result of screening programmes and fast-improving diagnostic tools, writes European Alliance for Personalised Medicine (EAPM)...
With its upcoming sixth Presidency conference now only five weeks away, the European Alliance for Personalised Medicine is preparing for the ‘Personalised Medicine and the Big Data...
Health technology assessment (HTA) is described by the World Health Organization as the systematic evaluation of properties, effects, and/or impacts of health technology, writes European Alliance...
When we talk about 'Big Data', what we mean is a massive collection of small data. In this case, it’s data garnered from individuals and used...
In these fast-changing times, with ageing populations and stunning breakthroughs in genomics, are we failing to ask the right questions in health care while making patients’...
Mark Lawler is a man of many talents. He’s a professor and cancer genomics expert at Queen’s University Belfast (QUB), an award-winning researcher, a scientific writer,...